Replies to post #212 on Corvus Pharmaceuticals Inc (CRVS)

[PatBoone]

Good back of the envelope calculation for the third line PTCL. But if the hypothesis on CPI-818 mechanism of action is correct, that you need a healthy normal ALC number, then the front line setting will make this a multi-blockbuster. Never mind the fantastic wet dream of CPI-818 also working in solid tumors. Somebody really should forward the CPI-818 data to Bob Dugan or Wayne Rothbaum because Miller just got lucky again, but he still hasn’t learned his lesson about focus and value creation.